Researchers at the National Center for Tumor Diseases (NCT/UCC) in Dresden, including Oliver Bruns and Dr. Bernardo Arús, are participating in an international study that has, for the first time, ...

Every year, about 85,000 Americans are diagnosed with bladder cancer. While treatment is often successful, bladder cancer has one of the highest rates of recurrence of any cancer: Following treatment, ...

Much of the public debate over cancer blood tests has focused on early detection products like the Galleri test from a company called Grail, which promises to screen healthy people for more than 50 ...

If you could know your risk for developing cancer, would you want to? Increasingly, people are saying yes. Personalized cancer screening and detection tests have surged in recent years, and accessing ...

Cancer claims more than 10 million lives every year globally. Research shows that detecting cancer early can greatly improve a patient's chance of survival. And yet we lack reliable, affordable tools ...

ROCHESTER, Minn. — Minnesota's world-renowned Mayo Clinic continues to live up to its reputation for achieving medical miracles, announcing Wednesday it has developed a test to detect pancreatic ...

The United States Food and Drug Administration (FDA) issued guidance on its “Breakthrough Devices Program” in 2023. The program grants a designation to certain medical devices that provide more ...

This repository provides code and workflows to test several state-of-the-art vehicle detection deep learning algorithms —including YOLOX, SalsaNext, and RandLA-Net— on a Flash Lidar dataset. The ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. This voice experience is generated by AI. Learn more. This voice ...

Multicancer blood tests have for years been hyped as a potential breakthrough in early cancer detection. But with news that one of the big names in the field, the Galleri test, failed to meet its ...